List of Tables
Table 1. Global Peptide Antibiotics Sterile Injectable Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptide Antibiotics Sterile Injectable Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptide Antibiotics Sterile Injectable Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptide Antibiotics Sterile Injectable Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptide Antibiotics Sterile Injectable Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptide Antibiotics Sterile Injectable Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptide Antibiotics Sterile Injectable Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide Antibiotics Sterile Injectable Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Antibiotics Sterile Injectable Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Antibiotics Sterile Injectable Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Antibiotics Sterile Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Antibiotics Sterile Injectable Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptide Antibiotics Sterile Injectable Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Peptide Antibiotics Sterile Injectable Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Peptide Antibiotics Sterile Injectable Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptide Antibiotics Sterile Injectable Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Peptide Antibiotics Sterile Injectable Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Peptide Antibiotics Sterile Injectable Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Peptide Antibiotics Sterile Injectable Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Peptide Antibiotics Sterile Injectable Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Peptide Antibiotics Sterile Injectable Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptide Antibiotics Sterile Injectable Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Peptide Antibiotics Sterile Injectable Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Peptide Antibiotics Sterile Injectable Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Peptide Antibiotics Sterile Injectable Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Peptide Antibiotics Sterile Injectable Drugs Product
Table 79. Novartis Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Peptide Antibiotics Sterile Injectable Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Takeda Pharmaceutical Co. Ltd Company Information
Table 86. Takeda Pharmaceutical Co. Ltd Description and Business Overview
Table 87. Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Pharmaceutical Co. Ltd Peptide Antibiotics Sterile Injectable Drugs Product
Table 89. Takeda Pharmaceutical Co. Ltd Recent Developments/Updates
Table 90. GlaxoSmithKline Company Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Peptide Antibiotics Sterile Injectable Drugs Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Abbott Laboratories Company Information
Table 96. Abbott Laboratories Description and Business Overview
Table 97. Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Abbott Laboratories Peptide Antibiotics Sterile Injectable Drugs Product
Table 99. Abbott Laboratories Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sanofi Peptide Antibiotics Sterile Injectable Drugs Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Baxter International Company Information
Table 106. Baxter International Description and Business Overview
Table 107. Baxter International Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Baxter International Peptide Antibiotics Sterile Injectable Drugs Product
Table 109. Baxter International Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. AstraZeneca Peptide Antibiotics Sterile Injectable Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Merck Company Information
Table 116. Merck Description and Business Overview
Table 117. Merck Peptide Antibiotics Sterile Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Merck Peptide Antibiotics Sterile Injectable Drugs Product
Table 119. Merck Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Peptide Antibiotics Sterile Injectable Drugs Distributors List
Table 123. Peptide Antibiotics Sterile Injectable Drugs Customers List
Table 124. Peptide Antibiotics Sterile Injectable Drugs Market Trends
Table 125. Peptide Antibiotics Sterile Injectable Drugs Market Drivers
Table 126. Peptide Antibiotics Sterile Injectable Drugs Market Challenges
Table 127. Peptide Antibiotics Sterile Injectable Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptide Antibiotics Sterile Injectable Drugs
Figure 2. Global Peptide Antibiotics Sterile Injectable Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Antibiotics Sterile Injectable Drugs Market Share by Type: 2024 & 2031
Figure 4. Ribosomal Synthesized Peptides Product Picture
Figure 5. Non-ribosomal Synthesized Peptides Product Picture
Figure 6. Global Peptide Antibiotics Sterile Injectable Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide Antibiotics Sterile Injectable Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Peptide Antibiotics Sterile Injectable Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Peptide Antibiotics Sterile Injectable Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Peptide Antibiotics Sterile Injectable Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Peptide Antibiotics Sterile Injectable Drugs Average Price (US$/Unit) & (2020-2031)
Figure 15. Peptide Antibiotics Sterile Injectable Drugs Report Years Considered
Figure 16. Peptide Antibiotics Sterile Injectable Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Peptide Antibiotics Sterile Injectable Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Peptide Antibiotics Sterile Injectable Drugs Players: Market Share by Revenue in Peptide Antibiotics Sterile Injectable Drugs in 2024
Figure 19. Peptide Antibiotics Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Peptide Antibiotics Sterile Injectable Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Peptide Antibiotics Sterile Injectable Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Peptide Antibiotics Sterile Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Peptide Antibiotics Sterile Injectable Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Peptide Antibiotics Sterile Injectable Drugs by Type (2020-2031)
Figure 56. Global Peptide Antibiotics Sterile Injectable Drugs Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Peptide Antibiotics Sterile Injectable Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Peptide Antibiotics Sterile Injectable Drugs by Application (2020-2031)
Figure 59. Global Peptide Antibiotics Sterile Injectable Drugs Price (US$/Unit) by Application (2020-2031)
Figure 60. Peptide Antibiotics Sterile Injectable Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
